Zim Launches Six Pharmaceutical Start-Ups at UZ In...

Zim Launches Six Pharmaceutical Start-Ups at UZ Innovation Week

Oscar J Jeke | Zim Now Reporter

Zimbabwe has launched six pharmaceutical start-ups aimed at advancing local drug production and reducing reliance on imports.

The announcement was made at the opening of the University of Zimbabwe’s 2025 Research, Innovation and Industrialization Week in Harare on Wednesday.

The launch was officiated by Minister of Skills Audit and Development, Professor Paul Mavima, standing in for the Minister of Higher and Tertiary Education, Innovation, Science and Technology Development, Ambassador Dr. Frederick Shava, who served as Guest of Honour.

Targeting key health challenges such as osteoporosis, allergic reactions, obesity, sunburn, heat strokes, immunity deficiencies, and fertility issues, the new ventures are positioned to produce affordable and accessible therapeutic solutions locally.

“The future we want will be built by the hands, minds, and creativity we nurture today. The time to act is now,” said Mavima during his keynote address.

The initiative marks a major milestone in Zimbabwe’s strategy to use science and innovation as levers for economic transformation. It also highlights ongoing efforts to align university research with national development goals, particularly in the health sector.

Running throughout the week, the UZ Innovation Week features exhibitions, panel discussions, and networking sessions involving students, researchers, policy-makers, and private sector stakeholders. The six start-ups are part of a broader push to commercialize academic research and create high-impact local industries.

The pharmaceutical industry in Zimbabwe has long struggled with import dependence and foreign currency shortages. The establishment of these start-ups—backed by government and institutional support—offers a potential turnaround by fostering domestic production and employment.

Early-stage development and clinical trials for the new ventures are expected to begin in the coming months, with plans to scale up for both national and regional distribution.